Pharmacokinetics of antibiotics with special emphasis on cephalosporins

Clinical Microbiology and Infection

Volumn 6, Issue S3, 2000, Pages 46-49

  Craig, W A ^a  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFMENOXIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ENOXACIN; LATAMOXEF; PLASMA PROTEIN;

AREA UNDER THE CURVE; ARTICLE; DRUG BILE LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG MUSCLE LEVEL; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; DRUG URINE LEVEL; GLOMERULUS FILTRATION; INTERSTITIAL FLUID; KIDNEY CLEARANCE; KIDNEY TUBULE EXCRETION; PLASMA CONCENTRATION-TIME CURVE; TISSUE HOMOGENATE; ANIMAL; BLOOD; HUMAN; REVIEW; URINE;

ANIMALS; CEPHALOSPORINS; HUMANS;

EID: 17944378850     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2000.tb02040.x     Document Type: Article

References (18)

1. Eagle H, Fleischman R, Musselman AD. Effect of schedule of administration on the therapeutic efficacy of penicillin. Am J Med 1950; 9: 280-99.
2. Vogelman B, Gudmundsson S, Leggert J, Turnidge J, Ebert S, Craig WA. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 1988; 158: 831-47.
3. Leggett J, Fantin B, Ebert S et al. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh infection models. J Infect Dis 1989; 159: 281-92.
4. Redington J, Ebert SC, Craig WA. Role of antimicrobial pharmacokinetics and pharmacodynamics in surgical prophylaxis. Rev Infect Dis 1991; 13(Suppl 10): S790-9.
5. Van Etta LL, Peterson LR, Fasching CE, Gerding DN. Effect of the ratio of surface area to volume on the penetration of antibiotics into extravascular spaces in an in-vitro model. J Infect Dis 1982; 146: 423-8.
6. Kaloger T, Digroves A, Bergan T, Solberg CO. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid. J Antimicrob Chemother 1984; 13: 479-85.
7. Hoffstedt B, Walder M. Influence of serum protein binding and mode of administration on penetration of five cephalosporins into subcutaneous tissue fluid in humans. Antimicrob Agents Chemother 1981; 20: 783-6.
8. Craig WA, Vogelman B. Changing concepts and new applications of antibiotic pharmacokinetics. Am J Med 1984; 77(Suppl. 1B): 24-8.
9. Vogelman BS, Craig WA. The pharmacokinetics of the third-generation cephalosporins in man: a review. In: Klastersky J, ed. Nosocomial Infections: Current Problems and Role of New Cephalosporins. Bruxelles, Belgium: Imprimerie Europrint, 1983: pp. 51-70.
10. Lutsar I, McCracken GH, Friedland IA. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1998; 27: 1117-29.
11. Fishman RA. Blood brain and CSF barriers to penicillin and related organic acids. Arch Meurol 1966; 15: 113-24.
12. Spector R. Ceftriaxone transport through the blood-brain barrier. J Infect Dis 1987; 1556: 209-11.
13. 14C-penicillin from cerebrospinal fluid to blood. J Phamaceut Sa 1969; 58: 1106-9.
14. Kishida K, Kobayashi K, Minagawa M, Sekine O, Watanabe K. Clinical Study of penetration of three antibiotics into cerebrospinal fluid: cefotaxime, cefmenoxime, and latamoxef. In: Ishigami, ed. Recent Advances in Chemotherapy. Tokoyo: University of Tokyo Press. 1985: pp. 720-1.
15. Nau R, Prange HW, Muth P et al. Passage of cefotaxime and ceftriaxone into cerebrospinal fluids of patients with inflamed meninges. Antimicrob Agents Chemother 1993; 37: 1516-24.
16. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 1995; 22: 89-96.
17. Craig WA, Gudmundsson S. Postantibiotic effect. In: Lorian V. ed. Antibiotics in Laboratory Medicine, 4th edn. Baltimore: Williams & Wilkins, 1996: pp. 296-329.
18. Andes D, Walker R, Ebert S, Craig W. Increasing protein binding of cefonicid enhances its in-vivo activity in an animal infection model. In: Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1994; 147.